{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:19:14Z","timestamp":1793488754874,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T00:00:00Z","timestamp":1473292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00108-016-0131-x","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T13:50:18Z","timestamp":1473342618000},"page":"1069-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management der Polymyalgia rheumatica und der Gro\u00dfgef\u00e4\u00dfvaskulitiden","Management of polymyalgia rheumatica and large vessel vasculitis"],"prefix":"10.1007","volume":"57","author":[{"given":"B.","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,8]]},"reference":[{"key":"131_CR1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1742-1241.2012.02981.x","volume":"66","author":"T Adizie","year":"2012","unstructured":"Adizie T, Christidis D, Dharmapaliah C et al (2012) Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series. Int J Clin Pract 66:906\u2013909","journal-title":"Int. J. Clin. Pract."},{"key":"131_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MD.0000000000000033","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Garcia-Martinez A, Prieto-Gonzalez S et al (2014) Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore) 93:194\u2013201","journal-title":"Medicine (Baltimore)"},{"key":"131_CR3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2015.12.015","volume":"37","author":"B Bienvenu","year":"2016","unstructured":"Bienvenu B, Ly KH, Lambert M et\u00a0al (2016) Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA). Rev Med Interne 37:154\u2013165","journal-title":"Rev Med Interne"},{"issue":"8","key":"131_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/rheumatology\/ken119","volume":"47","author":"D Blockmans","year":"2008","unstructured":"Blockmans D, Coudyzer W, Vanderschueren S et\u00a0al (2008) Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 47(8):1179\u20131184. doi: 10.1093\/rheumatology\/ken119","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0000000000000004","volume":"26","author":"A Clifford","year":"2014","unstructured":"Clifford A, Hoffman GS (2014) Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies. Curr Opin Rheumatol 26:7\u201315","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"131_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1136\/annrheumdis-2016-209351","volume":"75","author":"R Conway","year":"2016","unstructured":"Conway R, O\u2019Neill L, O\u2019Flynn E et\u00a0al (2016) Ustekinumab for the treatment of refractory giant cell arteritis. Ann Rheum Dis 75(8):1578\u20131579. doi: 10.1136\/annrheumdis-2016-209351","journal-title":"Ann Rheum Dis"},{"key":"131_CR7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N et\u00a0al (2010) BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 49:1594\u20131597","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492","journal-title":"Ann Rheum Dis"},{"key":"131_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semarthrit.2012.12.023","volume":"43","author":"H Boysson De","year":"2013","unstructured":"De Boysson H, Boutemy J, Creveuil C et al (2013) Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review. Semin Arthritis Rheum 43:105\u2013112","journal-title":"Semin Arthritis Rheum"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","volume":"45","author":"M Silva De","year":"1986","unstructured":"De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 45:136\u2013138","journal-title":"Ann Rheum Dis"},{"key":"131_CR11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et\u00a0al (2015) 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799\u20131807","journal-title":"Ann Rheum Dis"},{"key":"131_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","volume":"55","author":"AP Diamantopoulos","year":"2016","unstructured":"Diamantopoulos AP, Haugeberg G, Lindland A et al (2016) The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford) 55:66\u201370","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR13","unstructured":"Fritzlen J, Younge B, Weyand CM et\u00a0al (2015) Second temporal artery biopsies in patients with temporal arteritis (abstract). Arthritis Rheumatol 67(suppl 10). http:\/\/acrabstracts.org\/abstracts\/second-temporal-artery-biopsies-in-patients-with-temporal-arteriitis-ta\/ . Zugegriffen: 2.9.2016"},{"key":"131_CR14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ et al (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454\u20131461","journal-title":"Arthritis Rheum"},{"key":"131_CR15","first-page":"S43","volume":"29","author":"JC Henes","year":"2011","unstructured":"Henes JC, Mueller M, Pfannenberg C et\u00a0al (2011) Cyclophosphamide for large vessel vasculitis: assessment of response by PET\/CT. Clin Exp Rheumatol 29:S43\u2013S48","journal-title":"Clin Exp Rheumatol"},{"key":"131_CR16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","volume":"146","author":"GS Hoffman","year":"2007","unstructured":"Hoffman GS, Cid MC, Rendt-Zagar KE et al (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146:621\u2013630","journal-title":"Ann Intern Med"},{"key":"131_CR17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA et\u00a0al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et\u00a0al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"131_CR19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","volume":"41","author":"TA Kermani","year":"2012","unstructured":"Kermani TA, Schmidt J, Crowson CS et al (2012) Utility of erythrocyte sedimentation rate and C\u2011reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41:866\u2013871","journal-title":"Semin Arthritis Rheum"},{"key":"131_CR20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","volume":"72","author":"TA Kermani","year":"2013","unstructured":"Kermani TA, Warrington KJ, Crowson CS et al (2013) Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 72:1989\u20131994","journal-title":"Ann Rheum Dis"},{"key":"131_CR21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3899\/jrheum.141347","volume":"42","author":"TA Kermani","year":"2015","unstructured":"Kermani TA, Warrington KJ, Cuthbertson D et\u00a0al (2015) Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study. J\u00a0Rheumatol 42:1213\u20131217","journal-title":"J Rheumatol"},{"key":"131_CR22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.14140056","volume":"273","author":"T Klink","year":"2014","unstructured":"Klink T, Geiger J, Both M et al (2014) Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology 273:844\u2013852","journal-title":"Radiology"},{"key":"131_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/BOR.0000000000000265","volume":"28","author":"MJ Koster","year":"2016","unstructured":"Koster MJ, Matteson EL, Warrington KJ (2016) Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis. Curr Opin Rheumatol 28:211\u2013217","journal-title":"Curr Opin Rheumatol"},{"key":"131_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/kev348","volume":"55","author":"C Labarca","year":"2016","unstructured":"Labarca C, Koster MJ, Crowson CS et al (2016) Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford) 55:347\u2013356","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/art.39740","author":"L Lally","year":"2016","unstructured":"Lally L, Forbess L, Hatzis C et\u00a0al (2016) A prospective open label phase IIa trial of Tocilizumab in the treatment of polymyalgia rheumatica. Arthritis Rheumatol. doi: 10.1002\/art.39740","journal-title":"Arthritis Rheumatol"},{"key":"131_CR26","unstructured":"Langford C, Cuthbertson D, Ytterberg SR et al (2015) A randomized double-blind trial of abatacept and glucocorticoids for the treatment of giant cell arteritis (abstract). Arthritis Rheumatol 67(suppl 10). http:\/\/acrabstracts.org\/abstract\/a-randomized-double-blind-trial-of-abatacept-and-glucocorticoids-for-the-treatment-of-giant-cell-ateritis\/ . Zugegriffen: 2.9.2016"},{"key":"131_CR27","first-page":"S70","volume":"30","author":"J Loock","year":"2012","unstructured":"Loock J, Henes J, Kotter I et\u00a0al (2012) Treatment of refractory giant cell arteritis with cyclophosphamide: a retrospective analysis of 35 patients from three centres. Clin Exp Rheumatol 30:S70\u2013S76","journal-title":"Clin Exp Rheumatol"},{"key":"131_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.semarthrit.2014.12.005","volume":"44","author":"J Loricera","year":"2015","unstructured":"Loricera J, Blanco R, Hernandez JL et al (2015) Tocilizumab in giant cell arteritis: multicenter open-label study of 22 patients. Semin Arthritis Rheum 44:717\u2013723","journal-title":"Semin Arthritis Rheum"},{"key":"131_CR29","unstructured":"Luqmani R, Lee E, Gillet M et al (2015) The role of ultrasound compared to biopsy of temproal arteries in the diagnosis and treatment of gianc cell arteritis: a diagnostic accuracy and cost-effectiveness study (abstract). Arthritis Rheumatol 67(suppl 10). http:\/\/acrabstracts.org\/abstract\/the-role-of-ultrasound-compared-to-biopsy-of-the-temporal-arteries-in-the-diagnosis-and-treatment-of-giant-cell-arteritis-a-diagnocstic-accuracy-and-cost-effectiveness-study\/ . Zugegriffen: 2.9.2016"},{"key":"131_CR30","doi-asserted-by":"crossref","first-page":"e000100","DOI":"10.1136\/rmdopen-2015-000100","volume":"1","author":"SL Mackie","year":"2015","unstructured":"Mackie SL, Koduri G, Hill CL et\u00a0al (2015) Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open 1:e000100","journal-title":"RMD Open"},{"key":"131_CR31","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"AD Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789\u20132797","journal-title":"Arthritis Rheum"},{"key":"131_CR32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","volume":"67","author":"VM Martinez-Taboada","year":"2008","unstructured":"Martinez-Taboada VM, Rodriguez-Valverde V, Carreno L et al (2008) A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 67:625\u2013630","journal-title":"Ann Rheum Dis"},{"key":"131_CR33","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","volume":"132","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Comarmond C, Resche-Rigon M et al (2015) Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients. Circulation 132:1693\u20131700","journal-title":"Circulation"},{"key":"131_CR34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00259-003-1144-y","volume":"30","author":"J Meller","year":"2003","unstructured":"Meller J, Strutz F, Siefker U et al (2003) Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730\u2013736","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"131_CR35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10067-014-2650-y","volume":"35","author":"S Mori","year":"2016","unstructured":"Mori S, Koga Y (2016) Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Clin Rheumatol 35:1367\u20131375","journal-title":"Clin Rheumatol"},{"key":"131_CR36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et\u00a0al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318\u2013323","journal-title":"Ann Rheum Dis"},{"key":"131_CR37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.151103","volume":"43","author":"G Ozen","year":"2016","unstructured":"Ozen G, Inanc N, Unal AU et\u00a0al (2016) Assessment of the new 2012 EULAR\/ACR clinical classification criteria for polymyalgia rheumatica: a prospective multicenter study. J\u00a0Rheumatol 43:893\u2013900","journal-title":"J Rheumatol"},{"key":"131_CR38","first-page":"S103","volume":"33","author":"P Patil","year":"2015","unstructured":"Patil P, Williams M, Maw WW et\u00a0al (2015) Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol 33:S103\u2013S106","journal-title":"Clin Exp Rheumatol"},{"key":"131_CR39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kem379","volume":"47","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 47:403\u2013408","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR40","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1097\/MD.0000000000000486","volume":"94","author":"S Prieto-Gonzalez","year":"2015","unstructured":"Prieto-Gonzalez S, Garcia-Martinez A, Tavera-Bahillo I et al (2015) Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study. Medicine (Baltimore) 94:e486","journal-title":"Medicine (Baltimore)"},{"key":"131_CR41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","volume":"146","author":"C Salvarani","year":"2007","unstructured":"Salvarani C, Macchioni P, Manzini C et\u00a0al (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 146:631\u2013639","journal-title":"Ann Intern Med"},{"key":"131_CR42","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2003.015651","volume":"63","author":"AK Scheel","year":"2004","unstructured":"Scheel AK, Meller J, Vosshenrich R et\u00a0al (2004) Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63:1507\u20131510","journal-title":"Ann Rheum Dis"},{"key":"131_CR43","first-page":"309","volume":"20","author":"WA Schmidt","year":"2002","unstructured":"Schmidt WA, Natusch A, Moller DE et\u00a0al (2002) Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 20:309\u2013318","journal-title":"Clin Exp Rheumatol"},{"key":"131_CR44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/rheumatology\/41.5.496","volume":"41","author":"WA Schmidt","year":"2002","unstructured":"Schmidt WA, Nerenheim A, Seipelt E et\u00a0al (2002) Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 41:496\u2013502","journal-title":"Rheumatology (Oxford)"},{"key":"131_CR45","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","volume":"73","author":"R Seror","year":"2014","unstructured":"Seror R, Baron G, Hachulla E et al (2014) Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial. Ann Rheum Dis 73:2074\u20132081","journal-title":"Ann Rheum Dis"},{"key":"131_CR46","doi-asserted-by":"crossref","first-page":"20150892","DOI":"10.1259\/bjr.20150892","volume":"89","author":"D Spira","year":"2016","unstructured":"Spira D, Xenitidis T, Henes J et\u00a0al (2016) MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study. Br J Radiol 89:20150892","journal-title":"Br J Radiol"},{"issue":"1","key":"131_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/03009742.2015.1060521","volume":"45","author":"C Terao","year":"2015","unstructured":"Terao C, Yoshifuji H, Nakajima T et\u00a0al (2015) Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application. Scand J Rheumatol 45(1):80\u201382. doi: 10.3109\/03009742.2015.1060521","journal-title":"Scand J Rheumatol"},{"key":"131_CR48","doi-asserted-by":"publisher","first-page":"912562","DOI":"10.1155\/2013\/912562","volume":"2013","author":"SH Unizony","year":"2013","unstructured":"Unizony SH, Dasgupta B, Fisheleva E et\u00a0al (2013) Design of the tocilizumab in giant cell arteritis trial. Int J Rheumatol 2013:912562. doi: 10.1155\/2013\/912562","journal-title":"Int J Rheumatol"},{"key":"131_CR49","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger PM, Adler S, Kuchen S et al (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387:1921\u20131927","journal-title":"Lancet"},{"key":"131_CR50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2013.161","volume":"9","author":"CM Weyand","year":"2013","unstructured":"Weyand CM, Goronzy JJ (2013) Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 9:731\u2013740","journal-title":"Nat Rev Rheumatol"},{"key":"131_CR51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMc1409960","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:1653","journal-title":"N Engl J Med"},{"key":"131_CR52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","volume":"121","author":"CM Weyand","year":"1994","unstructured":"Weyand CM, Hicok KC, Hunder GG et\u00a0al (1994) Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 121:484\u2013491","journal-title":"Ann Intern Med"},{"key":"131_CR53","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/rheumatology\/ket107","volume":"52","author":"T Xenitidis","year":"2013","unstructured":"Xenitidis T, Horger M, Zeh G et\u00a0al (2013) Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis. Rheumatology (Oxford) 52:1729\u20131731","journal-title":"Rheumatology (Oxford)"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0131-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:14:39Z","timestamp":1498342479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0131-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0131-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}